Jeremy Murphree, patient advocate | Morgellons Survey
THE SHORT ANSWER
We still don’t know how often the filaments described in Morgellons research occur in people without symptoms. Existing comparison studies have not settled whether these particular structures are more common in affected skin.
That uncertainty matters when you show a clinician a strand associated with your skin. To call it normal, we need to know what it is and where comparable structures occur. To use it as a disease marker, we need evidence that it helps distinguish a clinical condition.
I write as a patient advocate who has photographed fibers that appear embedded within layers of my own skin. They can look wiry at low magnification and flattened at higher magnification. Those observations prompted this question. The description examined here comes from published microscopy; my photographs have not been calibrated to measure strand width.
Watch the explainer
A visual introduction to the evidence, the look-alikes and the comparisons still needed. The article below provides the sources and their limitations.
What researchers mean by Morgellons fibers
The word fiber covers several different observations, including loose lint, ordinary hair, material caught in a crust, and strands reported within or projecting from tissue. Their appearance on a photograph does not make them equivalent specimens.
A useful starting point is Middelveen and colleagues’ 2013 study of four selected patients. Some colored or white filaments measured 10-40 micrometers across, or 0.01-0.04 millimeters. Electron microscopy showed varied forms, including flattened strands with wrinkled or frayed surfaces. This supplies a published description to test, rather than a universal size threshold. [1]
The later 2020 study required spontaneously developing skin lesions with embedded or projecting white, red, blue, green or black filaments. That lesion-based rule is more specific than merely finding a strand on skin. It is a proposed research definition whose ability to distinguish conditions still needs testing. [2]
Four questions, four kinds of evidence
1 · PRESENCE
Is the material real?
2 · LOCATION
Where is it in relation to the skin?
3 · IDENTITY
What is it?
4 · MEANING
What does the finding mean?
Is the material real?
A strand can be real even when its identity is uncertain. Normal skin grows hairs, sheds keratin-containing material and encounters environmental fibers. A patient and clinician can therefore agree that material exists while continuing to investigate what it is and why it is there.
Independent reports contain physical findings worth examining, even where specimen details remain incomplete. Caputo and colleagues’ 2022 abstract describes multiple biopsies and microscopic visualization of fibers in a patient whom the authors diagnosed with Morgellons in the setting of delusional infestation. A 2025 scalp report describes repeated dermoscopic observations of multicolored filaments associated with skin and crusts; its fiber illustration shows material on a swab. These are observations to assess separately from the authors’ diagnostic interpretations. [3] [4]
Delusional infestation, or DI, concerns a fixed false belief about infestation. I distinguish that psychiatric assessment from a clinician-documented filament presentation, following the distinction discussed by Lai and colleagues. I make that distinction without claiming that a visible strand establishes a separate disease. A physical observation and the explanation attached to it require separate assessment: identifying a strand is one task; evaluating a person’s belief about it is another. [5]
Where is it in relation to the skin?
A strand on the surface, one caught in a healing crust and one documented within a skin specimen have different anatomical relationships. A hair emerging through the opening of a follicle, the small structure in which hair grows, also differs from unidentified material away from a follicle.
Known conditions provide useful comparisons. In a six-person circle-hair series, ordinary-looking hair shafts curved beneath the outermost skin layer or projected from it without local inflammation. Trichostasis spinulosa is a condition in which multiple fine hairs accumulate in the opening of a follicle; a 306-patient study documented its appearance under a dermoscope, a magnifying instrument used to examine skin. These findings help explain why something can look buried or tufted without representing a newly identified material. [6] [7]
Cutaneous pili migrans provides a documented example of a hair fragment embedded beneath the skin. In a biopsied case, a thin black strand was identified as a hair shaft in the upper part of the dermis, the deeper skin layer. The eruption resolved after the clinician removed it. [8]
Reactive perforating collagenosis offers a different comparison. In this recognized skin disorder, collagen from the dermis passes through a damaged area of the outer layer, the epidermis, into a surface plug. A 15-patient series demonstrated that process in tissue sections. This is abnormal tissue elimination, and it shows why an internally derived strand still needs a dermatological explanation. [9]
In Ohn and colleagues’ 2017 report, clinicians biopsied intact forearm skin and observed a black fiber protruding from the specimen’s dermal side. The fiber was absent from the processed sections, leaving its identity unresolved. The authors interpreted the case as DI. [10]
“Embedded” describes location; it does not explain how material arrived there. The practical task is to document a particular strand in its original position and follow it into a preserved specimen.
FOR PATIENTS
If you see fibers in your skin
Ask a clinician to examine the site and the photographs together. Take an overview showing the location and a focused close-up under consistent lighting; a ruler beside a lesion helps document its size. Keep a dated record of symptoms and whether the area had been scratched, treated or dressed. Avoid digging for a strand, which can injure the skin and change the finding. A photograph can show appearance and a place to examine. It cannot establish microscopic depth, chemical composition or the cells that produced the material. [11]
What is it?
Some normal human hairs fall within the reported filaments’ size range. In a study of 60 healthy women, researchers measured a minority of scalp hairs below 30 micrometers. A separate study of 120 healthy men also recorded fine hairs in that size category. That overlap does not establish a match in shape or tissue relationship, but it means diameter alone cannot separate the reported 10-40 micrometer filaments from all ordinary human hair. [1] [12] [13]
Small enough to overlap
These measurements use different methods and sites along a strand. Overlap in size does not establish the same identity.
Rakowska measured hair thickness at 70-fold magnification close to follicular openings and limited the proposed norms to adult white women. These scalp measurements are not directly interchangeable with widths measured elsewhere along an isolated filament. [12]
The fine, often lightly pigmented hairs commonly called peach fuzz are known as vellus hairs. Chang’s microscopy report of healthy cheek hair gives diameters of about 16 micrometers near the root and 11 micrometers midway along the shaft. These are illustrative measurements from an abstract that supplies no cohort size, rather than population reference limits. They show how fine an ordinary hair can be. [14]
A flattened or ribbon-like appearance also needs careful interpretation. Cotton can appear as twisted ribbons under a microscope, but flattening alone cannot identify a fiber as cotton or establish a biological origin. A current forensic laboratory protocol treats that shape as one feature in a wider identification process. [15]
Roncati and colleagues reported an environmental comparison in one patient: material from her skin lesions included human or pet hairs and plastic fibers that matched material from indoor air and a washing-machine filter. Their 2018 letter refers back to their earlier case. The authors concluded that the condition was self-induced. The match supports an environmental source; it does not by itself show how the material reached the skin. [16] [17]
In 2011, Middelveen and Stricker proposed a biological-filament explanation by comparing Morgellons with bovine digital dermatitis, an infectious skin disease of cattle that can produce keratin projections. The analogy did not establish the cause of the human presentation. It prompted a testable hypothesis that human skin cells might produce the reported filaments. [18]
In 2012, Middelveen and colleagues examined material from three patients and reported filaments associated with epithelial tissue and hair follicles. Filaments from two patients showed positive keratin staining, and chemical tests compared them with normal human hair. Their responses resembled hair in some tests but differed in bleach susceptibility. The authors interpreted the findings as evidence of production by skin cells and considered some colored fibers to be modified hairs. These findings inform the origin question, while leaving the frequency of these structures in unaffected skin unmeasured. [23]
The 2013 study extended this work using tissue sections, electron microscopy and stains for keratin and collagen. Two of its four patients had appeared in the 2012 report, so the studies are not independent patient series. [1] [23] Keratin is a structural protein in hair and the outer skin; collagen supports the deeper skin. The authors interpreted their findings as evidence of cellular production. The important next comparison is with ordinary hair, abnormal keratin formation, wound repair and other disorders that can alter these same proteins. [1]
The 2026 Twenty Year Odyssey paper adds previously unpublished accounts of older analyses. One account describes electron microscopy of a single hair-like fiber, while protein testing used fibers ground together. The reported protein matches included keratin and albumin, a blood protein; another protein band remained unidentified. These are relevant analytical observations, but results from pooled material cannot be assigned automatically to one imaged strand. The distinction matters when trying to identify exactly what a patient is seeing. [19]
What does the finding mean?
Identifying a strand does not establish why the skin is sore or inflamed. Ordinary hair can be present in diseased skin, while altered keratin or collagen may reflect injury, repair or a skin disorder.
WHAT THIS MEANS FOR YOU
For a patient, a strand in the skin is a reason to have it examined where it sits. A strand alone proves neither a disease nor a delusion. Some structures that look buried are ordinary hairs, as the circle-hair reports show. [6]
Clinic cohorts illustrate why the selection rule matters. Savely and Stricker compared the symptoms of patients with clinician-observed fibers with those of Lyme disease patients without fiber complaints. [24] In Harvey’s self-defined cohort, filaments were identified on examination in fewer than one-third. [28] Mayne recorded microscopy-confirmed Morgellons in about 6% of patients assessed for possible Lyme disease. [26] Fesler and colleagues identified 62 patients with Morgellons among 1,000 Lyme-seropositive clinic patients. [25] These studies describe differently selected clinical populations. Applying the same filament definition across them would make their structural findings comparable.
In a cohort selected through a DI assessment, Hylwa and colleagues reviewed 108 patients; 80 underwent biopsies. The outcome was evidence of infestation, not a comparison of particular fiber structures. No biopsy supported infestation, while 49 of the 80 showed dermatitis. The study documented physical skin changes alongside negative infestation findings. [27]
The CDC-led 2012 study had no unaffected comparison group; its biopsies, including samples of skin without visible lesions, came from symptomatic participants. Some analyzed material was cellulose consistent with cotton. In biopsy sections, detected foreign material usually lay in superficial crust, at a tissue edge or separate from tissue. Two biopsies showed foreign-body reactions: one with cotton-compatible fragments and the other with silicon-containing material, likely silicates. Both sites had features of prior ulceration or trauma. The authors found no common underlying medical condition or infectious source and could not determine whether the presentation was a new condition or an existing one such as DI. [22]
Some laboratory studies included healthy comparison material, but measured other features of the skin. The 2019 biofilm study used normal foot callus from three healthy people alongside other controls. Keller and colleagues’ 2024 biopsy study reports increased expression of the signaling protein oncostatin M relative to healthy controls. [20] [21]
A DI diagnosis, clinician-observed lesion filaments and self-reported fibers are different ways of selecting people. Examining these groups with the same methods would reveal how much they overlap and whether the same structures occur in each.
FOR CLINICIANS
What clinicians can record
When a strand is visible, record it in its original position with a calibrated scale, its relation to a follicular opening, and whether the surrounding skin is intact, inflamed, crusted or ulcerated. If sampling is clinically indicated, photograph the site before collection, preserve the strand’s relationship to tissue where possible, and document handling and potential contamination. Matching the photographed object to the analyzed object makes the resulting interpretation more useful.
The differential includes circle hairs, trichostasis spinulosa, perforating dermatoses, textile fibers and cutaneous pili migrans. [6] [7] [8] [9] [15]
The comparison that could answer the question
The next study should define the finding before assigning participants to explanatory categories. The definition would record size, contour, color under standardized lighting and anatomical location. It should distinguish a hair emerging from a follicle from a strand lodged in crust or present within tissue.
Researchers could then examine symptomatic participants, unaffected volunteers and people with relevant skin disorders using the same methods at comparable body sites. DI should be assessed independently so its relationship to the physical finding can be measured. Observers reviewing images and specimens should not know which group supplied them. Where sampling is justified, the same documented strand should undergo the appropriate structural and chemical examination, with collection controls.
The outcome would be practical: how often each structure occurs, which features differ between groups, and whether those differences relate to symptoms or pathology. That would help clinicians explain benign findings, recognize established skin disorders and identify any remaining pattern that deserves further study. It would also give patients a better answer than an assumption about what a fiber must mean.
Explore the evidence
References
[1] Middelveen MJ, Mayne PJ, Kahn DG, Stricker RB. Characterization and evolution of dermal filaments from patients with Morgellons disease. 2013. 10.2147/ccid.s39017.
[2] Middelveen MJ, Martinez RM, Fesler MC, Sapi E, Burke J, Shah JS, Nicolaus C, Stricker RB. Classification and Staging of Morgellons Disease: Lessons from Syphilis. 2020. 10.2147/ccid.s239840.
[3] Caputo V, Bonoldi E, Citterio A, Rongioletti F. The challenge of Morgellons disease: A patient with clinicopathologic correlation. 2022. 10.1016/j.clindermatol.2022.07.003.
[4] Fiorese G, Uribe NC, Trüeb RM. Morgellons-like Disease of the Scalp. 2025. 10.4103/ijt.ijt_72_24.
[5] Lai J, Xu Z, Xu Y, Hu S. Reframing delusional infestation: perspectives on unresolved puzzles. 2018. 10.2147/PRBM.S166720.
[6] Lacarrubba Francesco, Misciali Cosimo, Gibilisco Raffaele, Micali Giuseppe. Circle Hairs: Clinical, Trichoscopic and Histopathologic Findings. 2013. 10.4103/0974-7753.130415.
[7] Kelati A, Aqil N, Mernissi FZ. Dermoscopic Findings and Their Therapeutic Implications in Trichostasis Spinulosa: A Retrospective Study of 306 Patients. 2018. 10.1159/000486541.
[8] Kim Yoon Hwan, Kim Jung In, Hwang Sang Hyeon, Min Joon Hong, Chae Seoung Wan, Lee Seung Jae, Lee Ga-Young, Kim Won-Serk, Park Ji-Hye. Cutaneous Pili Migrans. 2014. 10.5021/ad.2014.26.4.534.
[9] Kollipara Haritha, Satya Ruttala S, Rao Gandikota R, Attili Sasi K. Acquired Reactive Perforating Collagenosis: Case Series. 2023 (online 2022). 10.4103/idoj.idoj_373_22.
[10] Ohn J, Park SY, Moon J, Choe YS, Kim KH. Morgellons Disease. 2017. 10.5021/ad.2017.29.2.223.
[11] American Academy of Dermatology. How to take pictures of your skin for your dermatologist. Accessed November 13, 2026. Source.
[12] Rakowska A. Trichoscopy (hair and scalp videodermoscopy) in the healthy female. Method standardization and norms for measurable parameters. 2009. 10.3315/jdcr.2008.1021.
[13] Asfiya Amina, Pinto Malcolm, Shenoy Manjunath Mala, Hegde Spandana P, Rajeendran Atul, Shafi Fathima. Trichoscopic Analysis of Healthy Indian Males for Standardization of the Measurable Parameters: An Observational, Cross-sectional Study. 2025; online 2024. 10.4103/idoj.idoj_201_24.
[14] Chang BS. Morphological Characteristics of Vellus Hair on Face Skin. 2018. 10.15810/jic.2018.14.2.003.
[15] Oklahoma State Bureau of Investigation. Trace Analysis Protocol Manual, Revision 8, TR-170 Fiber Analysis, pp. 57-59. Effective November 30, 2024. Source.
[16] Roncati L, Gatti AM, Pusiol T, Piscioli F, Barbolini G, Maiorana A. The first investigative science-based evidence of Morgellons psychogenesis. 2016. 10.1080/01913123.2016.1190434.
[17] Roncati L, Piscioli F. Morgellons Disease: Truth & Belief. 2018. 10.5021/ad.2018.30.3.361.
[18] Middelveen MJ, Stricker RB. Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease. 2011. 10.2147/CCID.S26183.
[19] Middelveen MJ, Fesler MC, Stricker RB. The Cellular Origin of Morgellons Disease Fibers: A Twenty Year Odyssey. 2026. 10.26502/acbr.50170529.
[20] Middelveen MJ, Filush KR, Bandoski C, Kasliwala RS, Melillo A, Stricker RB, Sapi E. Mixed Borrelia burgdorferi and Helicobacter pylori Biofilms in Morgellons Disease Dermatological Specimens. 2019. 10.3390/healthcare7020070.
[21] Keller JJ, Liu Y, Latour E. Skin biopsies of patients with Morgellon's disease show increased oncostatin M expression relative to healthy controls. 2024; first published online December 7, 2023. 10.1007/s00403-023-02768-2.
[22] Pearson ML, Selby JV, Katz KA, Cantrell V, Braden CR, Parise ME, Paddock CD, Lewin-Smith MR, Kalasinsky VF, Goldstein FC, Hightower AW, Papier A, Lewis B, Motipara S, Eberhard ML, Unexplained Dermopathy Study Team. Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy. 2012. 10.1371/journal.pone.0029908.
[23] Middelveen MJ, Rasmussen EH, Kahn DG, Stricker RB. Morgellons Disease: A Chemical and Light Microscopic Study. 2012. 10.4172/2155-9554.1000140.
[24] Savely VR, Stricker RB. Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology. 2010. 10.2147/CCID.S9520.
[25] Fesler MC, Middelveen MJ, Stricker RB. Clinical evaluation of Morgellons disease in a cohort of North American patients. 2018. 10.4081/dr.2018.7660.
[26] Mayne PJ. Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis, and ehrlichiosis in an Australian cohort. 2015; online December 23, 2014. 10.2147/IJGM.S75825.
[27] Hylwa SA, Bury JE, Davis MDP, Pittelkow M, Bostwick JM. Delusional infestation, including delusions of parasitosis: results of histologic examination of skin biopsy and patient-provided skin specimens. 2011. 10.1001/archdermatol.2011.114.
[28] Harvey WT, Bransfield RC, Mercer DE, Wright AJ, Ricchi RM, Leitao MM. Morgellons disease, illuminating an undefined illness: a case series. 2009. 10.4076/1752-1947-3-8243.
The research supplement below contains source-access notes, grouped study comparisons and the initial PubMed search record.
Research notes and source access
Search scope. The initial PubMed search on November 13, 2026 returned 119 records for “Morgellons.” Citation checking and focused searches covered earlier clinical cohorts, the 2012 chemical study, normal hair, hair-retention disorders, perforating skin disease and forensic fiber identification. This is a targeted narrative review. It was not preregistered, and no direct Embase or Scopus search was performed.
Source access. Full texts reviewed included Middelveen 2012, Savely and Stricker 2010, Harvey 2009, Mayne 2015, Fesler 2018, the 2026 Twenty Year Odyssey paper and both healthy-scalp-hair studies. Asfiya’s Table 1 reports mean thin-hair percentages below 30 micrometers of 9.9% frontally, 8.7% temporally and 8.0% occipitally. [13] Hylwa 2011 is assessed from its abstract. Roncati 2016 is assessed from its abstract and the full-text 2018 follow-up letter. [16] [17] Caputo 2022 is assessed from its abstract and publisher preview; Keller 2024, published online in December 2023, from the accessible publisher and institutional record. Chang 2018 is available as an English abstract without a cohort size, so its measurements are illustrative rather than population norms. [14]
Interpretation. Specimen findings, authors’ explanations and diagnostic usefulness are assessed separately. Reused or potentially overlapping cohorts are not summed. No numerical width is assigned to the author’s uncalibrated photographs. Symptom comparisons, clinic screening, laboratory hair controls and unaffected-tissue comparisons address different questions.
Author and disclosure. Jeremy Murphree is the founder of Morgellons Survey and writes as a patient advocate. His personal observations are disclosed in the article. This editorial analysis was prepared with AI assistance; it is not a peer-reviewed study or a report of independently examined specimens.
Study comparison
Studies of Morgellons and unexplained dermopathy
| Source | Sample | Finding relevant to the comparison |
|---|---|---|
| Harvey 2009 [28] | 25 self-defined patients | Filaments were identified on examination in fewer than one-third; broad clinical characterization without an unaffected filament comparison. |
| Savely and Stricker 2010 [24] | 122 fiber-positive patients; 60 Lyme symptom comparators | Fibers observed at 60-fold magnification; comparison concerned reported symptoms, not matched filament structure in unaffected skin. |
| Middelveen 2011 [18] | Comparative hypothesis | Keratin-producing skin cells proposed by analogy with a cattle dermatosis. |
| Middelveen 2012 [23] | 3 patients; chemical and keratin tests in 2 | Tissue/follicular associations, positive keratin staining and chemical comparison with normal hair; some colored filaments considered modified hairs. |
| Pearson 2012 [22] | 115 participants identified; 41 examined; 62 skin biopsies | Broad symptomatic case definition; no unaffected participant comparison group. |
| Middelveen 2013 [1] | 4 patients; 2 previously reported in 2012 | Some filaments 10-40 μm; varied morphology including flattened forms; tissue/staining evidence. |
| Mayne 2015 [26] | 500 patients assessed for possible Lyme disease | 29 classified with Morgellons by skin microscopy (5.8%); not a cohort consisting entirely of seropositive Lyme patients. |
| Fesler 2018 [25] | 1,000 clinic patients screened | 62 classified with Morgellons disease; 60 analyzed. Selected Lyme-seropositive clinic population. |
| Biofilm study 2019 [20] | 14 cases; several comparison sources | Foot callus from 3 healthy people, 2 Lyme patients without Morgellons disease, nonlesional material from 1 Morgellons disease patient, and commercial normal skin. |
| Middelveen 2020 [2] | 16 selected patients | Spontaneous lesions with embedded/projecting colored or white filaments; normal skin used in laboratory comparisons. |
| Keller 2024 [21] | Not verified from full methods | Title reports oncostatin M expression relative to healthy controls; not used here to infer a filament-prevalence result. |
| Middelveen et al. 2026 [19] | Historical and analytical synthesis | Older microscopy and protein accounts expanded; single-object imaging distinguished from pooled protein testing. |
Independent case reports
| Source | Sample | Finding relevant to the comparison |
|---|---|---|
| Roncati 2016 and 2018 [16] [17] | 2018 letter refers to earlier case | Reported human/pet hairs and plastic fibers matched household material; authors concluded self-induction. The 2016 full text was not available. |
| Ohn 2017 [10] | 1 patient | Clinician observed a black fiber on the dermal side of a biopsy; identity unresolved after processing. |
| Caputo 2022 [3] | 1 patient | Abstract describes multiple biopsies and microscopic fiber visualization; full specimen detail unavailable. |
| Fiorese et al. 2025 [4] | 1 patient | Dermoscopy reports filament association with skin/crust; figure shows strands on a swab. |
Delusional infestation cohorts
| Source | Sample | Finding relevant to the comparison |
|---|---|---|
| Hylwa 2011 [27] | 108 patients assessed for delusional infestation; 80 underwent biopsies | No biopsy supported infestation; 49 of 80 showed dermatitis. Assessed here from the abstract. |
Normal hair studies
| Source | Sample | Finding relevant to the comparison |
|---|---|---|
| Rakowska 2009 [12] | 60 healthy women | Thin hairs below 30 μm were a minority; measured at 70-fold magnification near follicular openings. Norms limited to adult white women. |
| Chang 2018 [14] | Size not in accessible abstract | Healthy cheek-hair measurements of approximately 16 μm proximally and 11 μm midshaft. |
| Asfiya et al. 2025 [13] | 120 healthy Indian men | Table 1: mean thin-hair percentages (<30 μm) 9.9% frontal, 8.7% temporal, 8.0% occipital. Online publication 2024. |
Recognized skin and hair conditions
| Source | Sample | Finding relevant to the comparison |
|---|---|---|
| Circle-hair series 2013 [6] | 6 men; 2 biopsied | Subcorneal or projecting coiled hair without local inflammation. |
| Cutaneous pili migrans 2014 [8] | 1 patient | Hair shaft confirmed in the superficial dermis; eruption resolved after clinician extraction. |
| Trichostasis study 2018 [7] | 306 clinic patients | Retained fine hairs in follicular openings; many findings incidental. |
| Reactive perforating collagenosis series 2023 [9] | 15 patients | Histological elimination of collagen through an epidermal crater. |
Initial PubMed search record with 119 hits
The initial PubMed query returned 119 records, not 119 verified cases. Screening labels describe each record’s role in the review. Additional healthy-hair and comparator sources are listed in the article’s references.
- 1935 — Sir Thomas Browne and the Disease Called the Morgellons. PMID 33943642. Context.
- 1946 — Myiasis, fillan, and the morgellons. PMID 20988616. Context.
- 2006 — The mystery of Morgellons disease: infection or delusion? PMID 16489838. Context.
- 2006 — Mysterious 'Morgellons disease' prompts US investigation. PMID 16960559. Context.
- 2006 — Pimozide at least as safe and perhaps more effective than olanzapine for treatment of Morgellons disease. PMID 17043201. Context.
- 2006 — Morgellons disease: a rapport-enhancing term for delusions of parasitosis. PMID 17052509. Context.
- 2006 — Morgellons disease? PMID 17052510. Context.
- 2006 — The challenge of Morgellons disease. PMID 17052516. Context.
- 2007 — Morgellons disease. PMID 17367622. Context.
- 2007 — Morgellons: disease or delusions? PMID 17388848. Context.
- 2008 — Morgellons disease? PMID 18318880. Context.
- 2008 — AKA 'Morgellons'. PMID 18434793. Context.
- 2008 — Delusional disorders in dermatology: a brief review. PMID 18713583. Context.
- 2008 — Morgellons disease and the 'tweezer sign'. PMID 18954416. Limited.
- 2008 — Delusional parasitosis facilitated by web-based dissemination. PMID 19047336. Limited.
- 2008 — Delusional parasitosis in ENT. PMID 23120590. Limited.
- 2009 — Morgellons disease as internet meme. PMID 19213978. Context.
- 2009 — Disorder or delusion? Living with Morgellons disease. PMID 19681520. Context.
- 2009 — Delusional infestation. PMID 19822895. Context.
- 2009 — Morgellons disease, illuminating an undefined illness: a case series. PMID 19830222. Mapped.
- 2009 — [Do they understand Morgellons disease?]. PMID 20039225. Context.
- 2010 — Morgellons in dermatology. PMID 19878403. Limited.
- 2010 — Morgellons: contested illness, diagnostic compromise and medicalisation. PMID 20149149. Context.
- 2010 — Intraoral Morgellons disease or delusional parasitosis: a first case report. PMID 20489569. Mapped.
- 2010 — Delusions may not always be delusions. PMID 20650366. Context.
- 2010 — Delusional parasitosis and the matchbox sign revisited: the international perspective. PMID 20814630. Limited.
- 2010 — Successful treatment of Morgellons disease with pimozide therapy. PMID 20956673. Limited.
- 2010 — Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet. PMID 21051675. Limited.
- 2010 — Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology. PMID 21437061. Mapped.
- 2011 — Morgellons disease and delusions of parasitosis. PMID 21110523. Limited.
- 2011 — Hypnosis in the treatment of Morgellons disease: a case study. PMID 21390982. Limited.
- 2011 — Psychosis, ivermectin toxicity, and "Morgellons disease". PMID 21565604. Limited.
- 2011 — An oral ulceration associated with Morgellons disease: a case report. PMID 21749875. Limited.
- 2011 — Delusional infestation with unusual pathogens: a report of three cases. PMID 21933231. Limited.
- 2011 — Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease. PMID 22253541. Mapped.
- 2012 — Dermatologic infestations. PMID 22250620. Context.
- 2012 — Delusional infestation: clinical presentation in 147 patients seen at Mayo Clinic. PMID 22264448. Limited.
- 2012 — Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy. PMID 22295070. Mapped.
- 2012 — Delusional infestation is typically comorbid with other psychiatric diagnoses: review of 54 patients receiving psychiatric evaluation at Mayo Clinic. PMID 22458994. Limited.
- 2012 — New findings in delusions of parasitosis. PMID 22545320. Limited.
- 2012 — Morgellons disease: more questions than answers. PMID 22959062. Context.
- 2012 — Variable clinical presentations of secondary delusional infestation: an experience of six cases from a psychodermatology clinic. PMID 23885516. Limited.
- 2012 — An approach to the evaluation of delusional infestation. PMID 24005827. Context.
- 2013 — Psychosomatic factors in pruritus. PMID 23245971. Context.
- 2013 — Characterization and evolution of dermal filaments from patients with Morgellons disease. PMID 23326202. Mapped.
- 2013 — [Morgellons syndrome: a disease transmitted via the media]. PMID 23328363. Context.
- 2013 — Delusions of parasitosis. PMID 23372213. Context.
- 2013 — Association of spirochetal infection with Morgellons disease. PMID 24715950. Mapped.
- 2013 — A case report highlighting the growing trend of Internet-based self-diagnosis of "Morgellon's disease". PMID 25073260. Limited.
- 2014 — Information, consent and treatment of patients with Morgellons disease: an ethical perspective. PMID 24671866. Context.
- 2015 — Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia burgdorferi in Morgellons disease patients. PMID 25879673. Mapped.
- 2016 — Morgellons Disease Presenting As an Eyelid Lesion. PMID 25192328. Limited.
- 2016 — The first investigative science-based evidence of Morgellons psychogenesis. PMID 27269255. Mapped.
- 2016 — Delusional Infestation: State of the Art. PMID 27282746. Context.
- 2016 — Morgellons disease: A myth or reality? PMID 27730047. Mapped.
- 2016 — Morgellons disease: a filamentous borrelial dermatitis. PMID 27789971. Context.
- 2017 — Exploring the Psychological Profile of Patients with Delusional Infestation. PMID 27026055. Limited.
- 2017 — History of Morgellons disease: the same name for different psychodermatologic diseases? PMID 28299553. Context.
- 2017 — Morgellons Disease. PMID 28392653. Mapped.
- 2017 — Formication, tactile hallucinations, delusional parasitosis, and Morgellons: Enough to make your skin crawl. PMID 28960311. Context.
- 2018 — Morgellons disease: experiences of an integrated multidisciplinary dermatology team to achieve positive outcomes. PMID 28665169. Limited.
- 2018 — Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease. PMID 29052453. Context.
- 2018 — Management of Morgellons Disease With Low-Dose Trifluoperazine. PMID 29322188. Limited.
- 2018 — History of Morgellons disease: from delusion to definition. PMID 29467580. Mapped.
- 2018 — Treatment of Oral Mucosal Lesions Associated With Overlapping Psychodermatologic Disorders. PMID 29600872. Limited.
- 2018 — Morgellons Disease-Dredged Up From History and Customized. PMID 29641827. Context.
- 2018 — Clinical evaluation of Morgellons disease in a cohort of North American patients. PMID 29774138. Mapped.
- 2018 — Morgellons Disease: Truth & Belief. PMID 29853755. Mapped.
- 2018 — Morgellons Disease: a Manifestation of Psychiatric Disorder. PMID 29853756. Mapped.
- 2018 — Reframing delusional infestation: perspectives on unresolved puzzles. PMID 30319296. Context.
- 2018 — Delusional infestation versus Morgellons disease. PMID 30446193. Context.
- 2018 — Use of antipsychotic drugs in dermatology. PMID 30446201. Context.
- 2018 — Detection of tick-borne infection in Morgellons disease patients by serological and molecular techniques. PMID 30519067. Mapped.
- 2018 — Morgellons disease: insights into treatment. PMID 30695970. Context.
- 2019 — Morgellons disease treatment with quetiapine. PMID 29706457. Limited.
- 2019 — Peripheral neuropathy associated with silver toxicity. PMID 30709965. Limited.
- 2019 — Mixed Borrelia burgdorferi and Helicobacter pylori Biofilms in Morgellons Disease Dermatological Specimens. PMID 31108976. Mapped.
- 2019 — Current Understanding and Approach to Delusional Infestation. PMID 31295443. Context.
- 2019 — Differentiating Psychosomatic, Somatopsychic, Multisystem Illnesses, and Medical Uncertainty. PMID 31597359. Context.
- 2019 — [Morgellons, a 'socially transmitted' disease]. PMID 31750635. Limited.
- 2019 — Morgellons disease leading to corneal perforation and enucleation. PMID 31836115. Limited.
- 2020 — Classification and Staging of Morgellons Disease: Lessons from Syphilis. PMID 32104041. Mapped.
- 2020 — Historical and clinical considerations on Ekbom's syndrome. PMID 32436416. Context.
- 2020 — Special Consideration for Patients With Morgellons Disease, Even Among Psychodermatology Patients?-Reply. PMID 32845295. Context.
- 2020 — Special Consideration for Patients With Morgellons Disease, Even Among Psychodermatology Patients? PMID 32845296. Context.
- 2020 — Is Morgellons an organic disease? structural and functional abnormalities implicated in the pathophysiology of delusional infestation. PMID 33342168. Context.
- 2021 — Morgellons Disease: The Spread of a Mass Psychogenic Illness via the Internet and Its Implications in Hand Surgery. PMID 33435739. Limited.
- 2021 — Delusional infestation complicated by gangrene and osteomyelitis requiring finger amputation. PMID 33869705. Limited.
- 2021 — Dermatological and Genital Manifestations of Lyme Disease Including Morgellons Disease. PMID 33986606. Mapped.
- 2021 — Morgellons disease etiology and therapeutic approach: a systematic review. PMID 34755952. Context.
- 2021 — Treatment of Morgellons disease with doxycycline. PMID 34917368. Mapped.
- 2021 — How to improve the interface between dermatology and psychiatry: a review and expert suggestion regarding the management of delusional patients. PMID 35130384. Context.
- 2022 — Treatment of tardive dyskinesia: a review and update for dermatologists managing delusions of parasitosis. PMID 33781159. Context.
- 2022 — Choosing the appropriate pharmacotherapy for Morgellons disease: an expert perspective. PMID 35076344. Context.
- 2022 — Morgellons Disease Treated as a Psychosomatic Condition. PMID 35755571. Limited.
- 2022 — "Doctor, You Must Examine My Creature Collection!": A Case Report of Delusional Infestation. PMID 35812529. Limited.
- 2022 — Management of delusions of parasitosis: an interview with experts in psychodermatology. PMID 35822193. Context.
- 2022 — Delusional parasitosis: an entomological perspective after a 20-years-experience in two public medical and veterinary entomology laboratories. PMID 35872007. Limited.
- 2022 — The challenge of Morgellons disease: A patient with clinicopathologic correlation. PMID 35905899. Mapped.
- 2022 — The Koo-Brownstone staging system as a tool to assist in the management of patients with a possible diagnosis of dermatological delusions: an experts suggestion. PMID 35950783. Context.
- 2022 — Self-inflicted pathological cutaneous disorders. Part I. PMID 36062949. Context.
- 2022 — Dermatology urgent care model reduces costs and healthcare utilization for psychodermatology patients – a retrospective chart review. PMID 36809128. Limited.
- 2022 — Treatments for Primary Delusional Infestation: Systematic Review. PMID 37632851. Context.
- 2023 — Delusional Parasitosis or Morgellons Disease: A Case of an Overlap Syndrome. PMID 37152271. Limited.
- 2024 (online 2023) — Skin biopsies of patients with Morgellon's disease show increased oncostatin M expression relative to healthy controls. PMID 38060036. Mapped.
- 2024 — Review of literature and clinical practice experience for the therapeutic management of Morgellons disease. PMID 38308572. Context.
- 2024 — Morgellons disease: a narrative review. PMID 38319480. Context.
- 2024 — Dupilumab as a novel therapy for management of delusions of parasitosis: A case series. PMID 38371665. Limited.
- 2024 — Perceived Conjunctival Foreign Material Egress in Morgellons Disease: A Case Study. PMID 38764875. Limited.
- 2024 — Skin Deep: An Overlap of Delusions. PMID 39036144. Limited.
- 2024 — Patients with Morgellons disease have a lower quality of life than patients with psoriasis, atopic dermatitis and prurigo nodularis. PMID 39166488. Limited.
- 2025 — Iron deficiency in Morgellons disease: unveiling the link. PMID 40072603. Limited.
- 2025 — Public perception of Morgellons disease: Lay media controversies and patient perspectives. PMID 40213533. Context.
- 2025 — Oral manifestations of Morgellons disease: current understanding of a psychiatric condition – a case series. PMID 40237592. Limited.
- 2025 — Morgellons Disease as a Delusional Parasitosis: A Case Presenting with Dermatological and Ocular Symptoms. PMID 40679805. Limited.
- 2025 — Morgellons-like Disease of the Scalp. PMID 41306834. Mapped.
- 2026 — Trigeminal trophic syndrome presenting as Morgellons disease with a 2-year delay in diagnosis. PMID 41551627. Mapped.
- 2026 — Evaluating the Role of Dermatologic Continuity and Determinants of Psychiatric Engagement in Delusional Infestation: A Single-Institution Cross-Sectional Study. PMID 41711132. Limited.
- 2026 — Response to letter from Fontaine et al. PMID 42495571. Context.